title: Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease.
authors.affiliation: San Paolo Hospital, University of Milan, Milan, Italy. maurizio.gallieni@fastwebnet.it
authors.forename: Maurizio
authors.initials: M
authors.lastname: Gallieni
authors.forename: Mario
authors.initials: M
authors.lastname: Cozzolino
authors.forename: Chiara
authors.initials: C
authors.lastname: Ronga
authors.forename: Diego
authors.initials: D
authors.lastname: Brancaccio
mesh_terms: D000075202:Contraindications; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D007676:Kidney Failure, Chronic; D011655:Pulmonary Embolism / Q000188:drug therapy*; D006435:Renal Dialysis; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D006495:Heparin, Low-Molecular-Weight